nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—asthma—chronic obstructive pulmonary disease	0.23	1	CtDrD
Isoprenaline—Arformoterol—chronic obstructive pulmonary disease	0.108	0.363	CrCtD
Isoprenaline—Formoterol—chronic obstructive pulmonary disease	0.108	0.363	CrCtD
Isoprenaline—Salbutamol—chronic obstructive pulmonary disease	0.0816	0.275	CrCtD
Isoprenaline—ADRB2—chronic obstructive pulmonary disease	0.0621	0.538	CbGaD
Isoprenaline—CYP1A1—chronic obstructive pulmonary disease	0.0533	0.462	CbGaD
Isoprenaline—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0244	0.2	CbGbCtD
Isoprenaline—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.024	0.197	CbGbCtD
Isoprenaline—Arformoterol—Formoterol—chronic obstructive pulmonary disease	0.0207	0.119	CrCrCtD
Isoprenaline—Formoterol—Arformoterol—chronic obstructive pulmonary disease	0.0207	0.119	CrCrCtD
Isoprenaline—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0185	0.152	CbGbCtD
Isoprenaline—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0185	0.152	CbGbCtD
Isoprenaline—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0182	0.149	CbGbCtD
Isoprenaline—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0182	0.149	CbGbCtD
Isoprenaline—Fenoterol—Formoterol—chronic obstructive pulmonary disease	0.0144	0.0826	CrCrCtD
Isoprenaline—Fenoterol—Arformoterol—chronic obstructive pulmonary disease	0.0144	0.0826	CrCrCtD
Isoprenaline—Phenylephrine—Salbutamol—chronic obstructive pulmonary disease	0.0129	0.0735	CrCrCtD
Isoprenaline—Arbutamine—Formoterol—chronic obstructive pulmonary disease	0.0126	0.0723	CrCrCtD
Isoprenaline—Arbutamine—Arformoterol—chronic obstructive pulmonary disease	0.0126	0.0723	CrCrCtD
Isoprenaline—Terbutaline—Salbutamol—chronic obstructive pulmonary disease	0.0118	0.0676	CrCrCtD
Isoprenaline—Isoetarine—Salbutamol—chronic obstructive pulmonary disease	0.0109	0.0626	CrCrCtD
Isoprenaline—Norepinephrine—Salbutamol—chronic obstructive pulmonary disease	0.0102	0.0584	CrCrCtD
Isoprenaline—Levonordefrin—Salbutamol—chronic obstructive pulmonary disease	0.00958	0.0548	CrCrCtD
Isoprenaline—Labetalol—Formoterol—chronic obstructive pulmonary disease	0.00801	0.0458	CrCrCtD
Isoprenaline—Labetalol—Arformoterol—chronic obstructive pulmonary disease	0.00801	0.0458	CrCrCtD
Isoprenaline—Epinephrine—Salbutamol—chronic obstructive pulmonary disease	0.00773	0.0442	CrCrCtD
Isoprenaline—Tachyarrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00163	0.0936	CcSEcCtD
Isoprenaline—Tachyarrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.0936	CcSEcCtD
Isoprenaline—PIK3R3—bronchus—chronic obstructive pulmonary disease	0.000895	0.103	CbGeAlD
Isoprenaline—PIK3R1—bronchus—chronic obstructive pulmonary disease	0.000764	0.0882	CbGeAlD
Isoprenaline—PIK3R1—trachea—chronic obstructive pulmonary disease	0.000686	0.0792	CbGeAlD
Isoprenaline—ADRBK1—respiratory system—chronic obstructive pulmonary disease	0.000642	0.0741	CbGeAlD
Isoprenaline—MAPK1—respiratory system—chronic obstructive pulmonary disease	0.000633	0.073	CbGeAlD
Isoprenaline—ADRB3—connective tissue—chronic obstructive pulmonary disease	0.000579	0.0667	CbGeAlD
Isoprenaline—PIK3R3—lung—chronic obstructive pulmonary disease	0.000577	0.0666	CbGeAlD
Isoprenaline—MAPK1—connective tissue—chronic obstructive pulmonary disease	0.000557	0.0643	CbGeAlD
Isoprenaline—Ventricular arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000527	0.0304	CcSEcCtD
Isoprenaline—ADRBK1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000517	0.0597	CbGeAlD
Isoprenaline—MAPK1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00051	0.0588	CbGeAlD
Isoprenaline—PIK3R1—lung—chronic obstructive pulmonary disease	0.000493	0.0569	CbGeAlD
Isoprenaline—ADRBK1—lung—chronic obstructive pulmonary disease	0.000341	0.0393	CbGeAlD
Isoprenaline—Pallor—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.0195	CcSEcCtD
Isoprenaline—MAPK1—lung—chronic obstructive pulmonary disease	0.000336	0.0388	CbGeAlD
Isoprenaline—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000251	0.0145	CcSEcCtD
Isoprenaline—Pulmonary oedema—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.0144	CcSEcCtD
Isoprenaline—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000248	0.0143	CcSEcCtD
Isoprenaline—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00024	0.0138	CcSEcCtD
Isoprenaline—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.000237	0.0273	CbGeAlD
Isoprenaline—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00023	0.0132	CcSEcCtD
Isoprenaline—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000226	0.013	CcSEcCtD
Isoprenaline—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.000225	0.0129	CcSEcCtD
Isoprenaline—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000221	0.0255	CbGeAlD
Isoprenaline—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000189	0.0109	CcSEcCtD
Isoprenaline—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000183	0.0106	CcSEcCtD
Isoprenaline—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.0106	CcSEcCtD
Isoprenaline—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.000182	0.0105	CcSEcCtD
Isoprenaline—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.0105	CcSEcCtD
Isoprenaline—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.000182	0.0105	CcSEcCtD
Isoprenaline—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.0101	CcSEcCtD
Isoprenaline—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000173	0.02	CbGeAlD
Isoprenaline—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00996	CcSEcCtD
Isoprenaline—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00987	CcSEcCtD
Isoprenaline—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000167	0.00964	CcSEcCtD
Isoprenaline—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.00954	CcSEcCtD
Isoprenaline—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000165	0.00951	CcSEcCtD
Isoprenaline—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.0092	CcSEcCtD
Isoprenaline—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.00873	CcSEcCtD
Isoprenaline—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00868	CcSEcCtD
Isoprenaline—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00866	CcSEcCtD
Isoprenaline—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00015	0.00862	CcSEcCtD
Isoprenaline—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.00851	CcSEcCtD
Isoprenaline—Orciprenaline—ADRB2—chronic obstructive pulmonary disease	0.000146	0.121	CrCbGaD
Isoprenaline—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.00824	CcSEcCtD
Isoprenaline—ADRB1—lung—chronic obstructive pulmonary disease	0.000143	0.0165	CbGeAlD
Isoprenaline—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000143	0.0165	CbGeAlD
Isoprenaline—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000142	0.00819	CcSEcCtD
Isoprenaline—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.008	CcSEcCtD
Isoprenaline—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000138	0.00795	CcSEcCtD
Isoprenaline—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.00782	CcSEcCtD
Isoprenaline—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00767	CcSEcCtD
Isoprenaline—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00767	CcSEcCtD
Isoprenaline—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000131	0.00753	CcSEcCtD
Isoprenaline—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00753	CcSEcCtD
Isoprenaline—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.00749	CcSEcCtD
Isoprenaline—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.00738	CcSEcCtD
Isoprenaline—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000128	0.0148	CbGeAlD
Isoprenaline—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00734	CcSEcCtD
Isoprenaline—Tension—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00734	CcSEcCtD
Isoprenaline—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.00726	CcSEcCtD
Isoprenaline—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000126	0.00726	CcSEcCtD
Isoprenaline—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000126	0.00725	CcSEcCtD
Isoprenaline—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00724	CcSEcCtD
Isoprenaline—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000124	0.00714	CcSEcCtD
Isoprenaline—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.007	CcSEcCtD
Isoprenaline—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000122	0.007	CcSEcCtD
Isoprenaline—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00693	CcSEcCtD
Isoprenaline—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000119	0.00686	CcSEcCtD
Isoprenaline—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00686	CcSEcCtD
Isoprenaline—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.00684	CcSEcCtD
Isoprenaline—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00661	CcSEcCtD
Isoprenaline—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00661	CcSEcCtD
Isoprenaline—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00661	CcSEcCtD
Isoprenaline—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000112	0.00647	CcSEcCtD
Isoprenaline—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000112	0.00645	CcSEcCtD
Isoprenaline—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.00645	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00639	CcSEcCtD
Isoprenaline—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00011	0.00634	CcSEcCtD
Isoprenaline—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.00634	CcSEcCtD
Isoprenaline—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.00624	CcSEcCtD
Isoprenaline—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00609	CcSEcCtD
Isoprenaline—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00599	CcSEcCtD
Isoprenaline—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00595	CcSEcCtD
Isoprenaline—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00595	CcSEcCtD
Isoprenaline—Hypotension—Arformoterol—chronic obstructive pulmonary disease	9.9e-05	0.0057	CcSEcCtD
Isoprenaline—Hypotension—Formoterol—chronic obstructive pulmonary disease	9.9e-05	0.0057	CcSEcCtD
Isoprenaline—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	9.77e-05	0.00562	CcSEcCtD
Isoprenaline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	9.67e-05	0.00557	CcSEcCtD
Isoprenaline—Terbutaline—ADRB2—chronic obstructive pulmonary disease	9.62e-05	0.0794	CrCbGaD
Isoprenaline—Insomnia—Arformoterol—chronic obstructive pulmonary disease	9.58e-05	0.00552	CcSEcCtD
Isoprenaline—Insomnia—Formoterol—chronic obstructive pulmonary disease	9.58e-05	0.00552	CcSEcCtD
Isoprenaline—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	9.45e-05	0.00544	CcSEcCtD
Isoprenaline—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	9.45e-05	0.00544	CcSEcCtD
Isoprenaline—Insomnia—Montelukast—chronic obstructive pulmonary disease	9.39e-05	0.0054	CcSEcCtD
Isoprenaline—Hypotension—Salbutamol—chronic obstructive pulmonary disease	9.35e-05	0.00538	CcSEcCtD
Isoprenaline—Isoetarine—ADRB2—chronic obstructive pulmonary disease	9.26e-05	0.0764	CrCbGaD
Isoprenaline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	9.21e-05	0.0053	CcSEcCtD
Isoprenaline—CYP1A1—lung—chronic obstructive pulmonary disease	9.2e-05	0.0106	CbGeAlD
Isoprenaline—Insomnia—Salbutamol—chronic obstructive pulmonary disease	9.05e-05	0.00521	CcSEcCtD
Isoprenaline—Sotalol—ADRB2—chronic obstructive pulmonary disease	8.95e-05	0.0738	CrCbGaD
Isoprenaline—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	8.92e-05	0.00514	CcSEcCtD
Isoprenaline—Headache—Aminophylline—chronic obstructive pulmonary disease	8.72e-05	0.00502	CcSEcCtD
Isoprenaline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	8.68e-05	0.005	CcSEcCtD
Isoprenaline—Nausea—Aminophylline—chronic obstructive pulmonary disease	8.27e-05	0.00476	CcSEcCtD
Isoprenaline—Headache—Tiotropium—chronic obstructive pulmonary disease	8.23e-05	0.00474	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.00465	CcSEcCtD
Isoprenaline—Fenoterol—ADRB2—chronic obstructive pulmonary disease	7.88e-05	0.065	CrCbGaD
Isoprenaline—Nausea—Tiotropium—chronic obstructive pulmonary disease	7.8e-05	0.00449	CcSEcCtD
Isoprenaline—Asthenia—Arformoterol—chronic obstructive pulmonary disease	7.6e-05	0.00438	CcSEcCtD
Isoprenaline—Asthenia—Formoterol—chronic obstructive pulmonary disease	7.6e-05	0.00438	CcSEcCtD
Isoprenaline—Asthenia—Montelukast—chronic obstructive pulmonary disease	7.45e-05	0.00429	CcSEcCtD
Isoprenaline—Arbutamine—ADRB2—chronic obstructive pulmonary disease	7.37e-05	0.0608	CrCbGaD
Isoprenaline—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	7.22e-05	0.00415	CcSEcCtD
Isoprenaline—Asthenia—Salbutamol—chronic obstructive pulmonary disease	7.18e-05	0.00413	CcSEcCtD
Isoprenaline—Formoterol—ADRB2—chronic obstructive pulmonary disease	7.15e-05	0.059	CrCbGaD
Isoprenaline—Salbutamol—ADRB2—chronic obstructive pulmonary disease	7.15e-05	0.059	CrCbGaD
Isoprenaline—Arformoterol—ADRB2—chronic obstructive pulmonary disease	7.15e-05	0.059	CrCbGaD
Isoprenaline—Dizziness—Formoterol—chronic obstructive pulmonary disease	7.01e-05	0.00403	CcSEcCtD
Isoprenaline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	7.01e-05	0.00403	CcSEcCtD
Isoprenaline—Dizziness—Montelukast—chronic obstructive pulmonary disease	6.86e-05	0.00395	CcSEcCtD
Isoprenaline—Headache—Arformoterol—chronic obstructive pulmonary disease	6.64e-05	0.00382	CcSEcCtD
Isoprenaline—Headache—Formoterol—chronic obstructive pulmonary disease	6.64e-05	0.00382	CcSEcCtD
Isoprenaline—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	6.63e-05	0.00382	CcSEcCtD
Isoprenaline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	6.62e-05	0.00381	CcSEcCtD
Isoprenaline—Headache—Montelukast—chronic obstructive pulmonary disease	6.5e-05	0.00374	CcSEcCtD
Isoprenaline—Vertigo—Prednisolone—chronic obstructive pulmonary disease	6.32e-05	0.00364	CcSEcCtD
Isoprenaline—Nausea—Arformoterol—chronic obstructive pulmonary disease	6.29e-05	0.00362	CcSEcCtD
Isoprenaline—Nausea—Formoterol—chronic obstructive pulmonary disease	6.29e-05	0.00362	CcSEcCtD
Isoprenaline—Headache—Salbutamol—chronic obstructive pulmonary disease	6.27e-05	0.00361	CcSEcCtD
Isoprenaline—Nausea—Montelukast—chronic obstructive pulmonary disease	6.17e-05	0.00355	CcSEcCtD
Isoprenaline—Convulsion—Prednisolone—chronic obstructive pulmonary disease	6.09e-05	0.00351	CcSEcCtD
Isoprenaline—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.07e-05	0.0035	CcSEcCtD
Isoprenaline—Nausea—Salbutamol—chronic obstructive pulmonary disease	5.94e-05	0.00342	CcSEcCtD
Isoprenaline—Phenylephrine—CYP1A2—chronic obstructive pulmonary disease	5.75e-05	0.0475	CrCbGaD
Isoprenaline—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	5.6e-05	0.00322	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	5.55e-05	0.00319	CcSEcCtD
Isoprenaline—Flushing—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.00314	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	5.24e-05	0.00302	CcSEcCtD
Isoprenaline—Labetalol—ADRB2—chronic obstructive pulmonary disease	5.23e-05	0.0431	CrCbGaD
Isoprenaline—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.19e-05	0.00299	CcSEcCtD
Isoprenaline—Pindolol—ADRB2—chronic obstructive pulmonary disease	5.02e-05	0.0414	CrCbGaD
Isoprenaline—Vision blurred—Prednisone—chronic obstructive pulmonary disease	4.82e-05	0.00277	CcSEcCtD
Isoprenaline—Vertigo—Prednisone—chronic obstructive pulmonary disease	4.59e-05	0.00264	CcSEcCtD
Isoprenaline—Convulsion—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.00255	CcSEcCtD
Isoprenaline—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.00254	CcSEcCtD
Isoprenaline—Droxidopa—ADRB2—chronic obstructive pulmonary disease	4.23e-05	0.0349	CrCbGaD
Isoprenaline—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.07e-05	0.00234	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.03e-05	0.00232	CcSEcCtD
Isoprenaline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	3.8e-05	0.00218	CcSEcCtD
Isoprenaline—Insomnia—Prednisone—chronic obstructive pulmonary disease	3.77e-05	0.00217	CcSEcCtD
Isoprenaline—Epinephrine—TNF—chronic obstructive pulmonary disease	3.65e-05	0.0301	CrCbGaD
Isoprenaline—Headache—Prednisolone—chronic obstructive pulmonary disease	3.6e-05	0.00207	CcSEcCtD
Isoprenaline—Norepinephrine—ADRB2—chronic obstructive pulmonary disease	3.56e-05	0.0294	CrCbGaD
Isoprenaline—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.41e-05	0.00196	CcSEcCtD
Isoprenaline—Epinephrine—ADRB2—chronic obstructive pulmonary disease	3.23e-05	0.0267	CrCbGaD
Isoprenaline—Dopamine—SLC6A4—chronic obstructive pulmonary disease	3.01e-05	0.0248	CrCbGaD
Isoprenaline—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.99e-05	0.00172	CcSEcCtD
Isoprenaline—Norepinephrine—CYP1A2—chronic obstructive pulmonary disease	2.95e-05	0.0243	CrCbGaD
Isoprenaline—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.76e-05	0.00159	CcSEcCtD
Isoprenaline—Dopamine—CYP1A2—chronic obstructive pulmonary disease	2.74e-05	0.0226	CrCbGaD
Isoprenaline—Epinephrine—CYP1A2—chronic obstructive pulmonary disease	2.67e-05	0.022	CrCbGaD
Isoprenaline—Headache—Prednisone—chronic obstructive pulmonary disease	2.61e-05	0.0015	CcSEcCtD
Isoprenaline—Nausea—Prednisone—chronic obstructive pulmonary disease	2.48e-05	0.00143	CcSEcCtD
Isoprenaline—PIK3R2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.85e-06	0.000114	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—TLR4—chronic obstructive pulmonary disease	3.84e-06	0.000114	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.82e-06	0.000113	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.81e-06	0.000113	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.79e-06	0.000112	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.78e-06	0.000112	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.78e-06	0.000112	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.77e-06	0.000112	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TP53—chronic obstructive pulmonary disease	3.77e-06	0.000111	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.77e-06	0.000111	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.71e-06	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.71e-06	0.00011	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.69e-06	0.000109	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.69e-06	0.000109	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—ALB—chronic obstructive pulmonary disease	3.68e-06	0.000109	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—KL—chronic obstructive pulmonary disease	3.67e-06	0.000109	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.59e-06	0.000106	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.53e-06	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.52e-06	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.52e-06	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—SERPINE1—chronic obstructive pulmonary disease	3.51e-06	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.5e-06	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.5e-06	0.000103	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	3.49e-06	0.000103	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.49e-06	0.000103	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.47e-06	0.000103	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—SERPINE1—chronic obstructive pulmonary disease	3.46e-06	0.000102	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.45e-06	0.000102	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.42e-06	0.000101	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.41e-06	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—NOS2—chronic obstructive pulmonary disease	3.38e-06	9.99e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.37e-06	9.97e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.37e-06	9.97e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—NOS3—chronic obstructive pulmonary disease	3.35e-06	9.91e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.32e-06	9.82e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—NOS3—chronic obstructive pulmonary disease	3.3e-06	9.77e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.3e-06	9.75e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	3.27e-06	9.68e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.23e-06	9.56e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.22e-06	9.54e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.22e-06	9.53e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD8A—chronic obstructive pulmonary disease	3.21e-06	9.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	3.2e-06	9.46e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.15e-06	9.33e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.15e-06	9.33e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.14e-06	9.3e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	3.14e-06	9.3e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.14e-06	9.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.13e-06	9.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.12e-06	9.23e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.12e-06	9.22e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—IL6—chronic obstructive pulmonary disease	3.1e-06	9.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL1B—chronic obstructive pulmonary disease	3.09e-06	9.14e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.08e-06	9.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.08e-06	9.12e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.07e-06	9.08e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.06e-06	9.05e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—IL6—chronic obstructive pulmonary disease	3.06e-06	9.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TP53—chronic obstructive pulmonary disease	3.05e-06	9.03e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	3.05e-06	9.02e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.04e-06	9.01e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL1B—chronic obstructive pulmonary disease	3.04e-06	9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—IL6—chronic obstructive pulmonary disease	3e-06	8.87e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.99e-06	8.86e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ERBB3—chronic obstructive pulmonary disease	2.98e-06	8.82e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—EGFR—chronic obstructive pulmonary disease	2.95e-06	8.73e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.95e-06	8.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.94e-06	8.71e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—ALB—chronic obstructive pulmonary disease	2.93e-06	8.68e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.88e-06	8.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.85e-06	8.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—SERPINE1—chronic obstructive pulmonary disease	2.84e-06	8.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.84e-06	8.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.81e-06	8.3e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.8e-06	8.28e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.79e-06	8.24e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—TGFB1—chronic obstructive pulmonary disease	2.78e-06	8.22e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.77e-06	8.19e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.77e-06	8.18e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ERBB3—chronic obstructive pulmonary disease	2.75e-06	8.15e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.75e-06	8.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.73e-06	8.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CRP—chronic obstructive pulmonary disease	2.73e-06	8.07e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—EGFR—chronic obstructive pulmonary disease	2.72e-06	8.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—NOS3—chronic obstructive pulmonary disease	2.71e-06	8.03e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—IL6—chronic obstructive pulmonary disease	2.71e-06	8.03e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.68e-06	7.92e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.66e-06	7.88e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.62e-06	7.75e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—TLR4—chronic obstructive pulmonary disease	2.61e-06	7.73e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.61e-06	7.73e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.57e-06	7.62e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.57e-06	7.61e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.57e-06	7.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.54e-06	7.51e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.54e-06	7.51e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.52e-06	7.46e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.52e-06	7.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—IL6—chronic obstructive pulmonary disease	2.51e-06	7.44e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL1B—chronic obstructive pulmonary disease	2.5e-06	7.4e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.48e-06	7.35e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.48e-06	7.33e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.46e-06	7.27e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.42e-06	7.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.4e-06	7.1e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—ALB—chronic obstructive pulmonary disease	2.38e-06	7.03e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.37e-06	7.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.36e-06	6.99e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.36e-06	6.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—EGFR—chronic obstructive pulmonary disease	2.35e-06	6.96e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.35e-06	6.94e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—EGFR—chronic obstructive pulmonary disease	2.32e-06	6.86e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.31e-06	6.84e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.31e-06	6.82e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS2—chronic obstructive pulmonary disease	2.29e-06	6.79e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.27e-06	6.73e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL6—chronic obstructive pulmonary disease	2.27e-06	6.71e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.22e-06	6.58e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—TGFB1—chronic obstructive pulmonary disease	2.21e-06	6.56e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.19e-06	6.49e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.18e-06	6.46e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—TGFB1—chronic obstructive pulmonary disease	2.18e-06	6.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—EGFR—chronic obstructive pulmonary disease	2.17e-06	6.43e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.16e-06	6.39e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.14e-06	6.34e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—EGFR—chronic obstructive pulmonary disease	2.14e-06	6.33e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.12e-06	6.28e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.12e-06	6.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—IL6—chronic obstructive pulmonary disease	2.09e-06	6.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.09e-06	6.17e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.08e-06	6.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—chronic obstructive pulmonary disease	2.07e-06	6.14e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.05e-06	6.07e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.04e-06	6.03e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.02e-06	5.98e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.01e-06	5.95e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.99e-06	5.89e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.98e-06	5.86e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.97e-06	5.83e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—chronic obstructive pulmonary disease	1.96e-06	5.79e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.95e-06	5.77e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.95e-06	5.76e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.94e-06	5.75e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.94e-06	5.74e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.94e-06	5.73e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.93e-06	5.72e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.93e-06	5.7e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.91e-06	5.65e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—EGFR—chronic obstructive pulmonary disease	1.91e-06	5.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.9e-06	5.62e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.88e-06	5.57e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.85e-06	5.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.85e-06	5.49e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.85e-06	5.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS3—chronic obstructive pulmonary disease	1.84e-06	5.46e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.82e-06	5.39e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.81e-06	5.37e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL6—chronic obstructive pulmonary disease	1.81e-06	5.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.81e-06	5.35e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFB1—chronic obstructive pulmonary disease	1.79e-06	5.31e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.78e-06	5.27e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—chronic obstructive pulmonary disease	1.78e-06	5.27e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.77e-06	5.23e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—EGFR—chronic obstructive pulmonary disease	1.76e-06	5.21e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.72e-06	5.1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.71e-06	5.06e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—chronic obstructive pulmonary disease	1.7e-06	5.03e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.69e-06	5e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.69e-06	4.99e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—chronic obstructive pulmonary disease	1.67e-06	4.94e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.66e-06	4.93e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.65e-06	4.89e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.65e-06	4.87e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—chronic obstructive pulmonary disease	1.64e-06	4.87e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.64e-06	4.86e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.62e-06	4.79e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.61e-06	4.76e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.6e-06	4.74e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.6e-06	4.74e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.58e-06	4.68e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.56e-06	4.63e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.55e-06	4.59e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.55e-06	4.58e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.53e-06	4.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.52e-06	4.51e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.52e-06	4.5e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.51e-06	4.48e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.5e-06	4.43e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.49e-06	4.42e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.49e-06	4.4e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.47e-06	4.35e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.47e-06	4.34e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—chronic obstructive pulmonary disease	1.46e-06	4.33e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.44e-06	4.25e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.42e-06	4.2e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.39e-06	4.12e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.37e-06	4.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.35e-06	4e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—chronic obstructive pulmonary disease	1.35e-06	4e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.34e-06	3.96e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—EGFR—chronic obstructive pulmonary disease	1.3e-06	3.83e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.29e-06	3.82e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.28e-06	3.78e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.26e-06	3.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.26e-06	3.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.23e-06	3.65e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.23e-06	3.63e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—chronic obstructive pulmonary disease	1.22e-06	3.61e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.21e-06	3.58e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.2e-06	3.56e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—EGFR—chronic obstructive pulmonary disease	1.2e-06	3.54e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.18e-06	3.5e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.17e-06	3.46e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.15e-06	3.41e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.15e-06	3.41e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.15e-06	3.39e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.13e-06	3.34e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.1e-06	3.26e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.09e-06	3.23e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.08e-06	3.19e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.04e-06	3.07e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.03e-06	3.06e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.01e-06	2.99e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—chronic obstructive pulmonary disease	9.96e-07	2.95e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.77e-07	2.89e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.55e-07	2.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.47e-07	2.8e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.31e-07	2.75e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.29e-07	2.75e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.24e-07	2.74e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—chronic obstructive pulmonary disease	9.19e-07	2.72e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.08e-07	2.69e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	8.96e-07	2.65e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.83e-07	2.61e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.64e-07	2.56e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.57e-07	2.54e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.54e-07	2.53e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.38e-07	2.48e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.93e-07	2.35e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.76e-07	2.3e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.28e-07	2.15e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.14e-07	2.11e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.12e-07	2.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.03e-07	2.08e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.98e-07	2.07e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.44e-07	1.91e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.99e-07	1.77e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.86e-07	1.74e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.49e-07	1.62e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.37e-07	1.59e-05	CbGpPWpGaD
